Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Lidocaine Infusion for Postthoracotomy Pain Syndrome, A Prospective, Randomized, Double-blind, Placebo-controlled Trial (LIPPS Trial)

NCT03666299 is registered in ClinicalTrials.gov with Guangzhou First People's Hospital as lead sponsor.

NCT NCT03666299
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03666299 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Lidocaine Infusion for Postthoracotomy Pain Syndrome, A Prospective, Randomized, Double-blind, Placebo-controlled Trial (LIPPS Trial)
Lead sponsor
Guangzhou First People's Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
November 6, 2018
Completion date
June 30, 2019
Enrollment
72 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain, lidocaine, pain, postoperative, thoracic surgery, video-assisted